Butane

Butane

SCHEMBL1472674

CCCC.[AlH3].[N-]=[N+]=[N-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL1774672 0.90
Butane SCHEMBL9060189 0.90
Butane SCHEMBL7063280 0.90
Butane SCHEMBL250788 0.78
Propanol SCHEMBL1922330 0.73
Pentane SCHEMBL28529129 0.73 TSHR (0.58)
Butane SCHEMBL483021 0.72
Butane SCHEMBL21562 0.72
Butane SCHEMBL10936920 0.72
Butane SCHEMBL3109038 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943647-B2 Process for the preparation of tetrazole derivatives from organo aluminium azides NOVARTIS AG (CH) 2011-05-17 US claimed
EP-1646636-B1 PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES NOVARTIS AG (CH) 2009-12-02 EP claimed
CN-110407898-B Amphotericin B derivatives with improved therapeutic index 伊利诺伊大学评议会 2023-12-01 CN disclosed
CN-110407898-A Amphotericin B derivatives with improved therapeutic index THE BOARD OF TRUSTEES OF THE UNIV OF ILLIONIS 2019-11-05 CN disclosed
CN-105848721-B Amphotericin B derivatives with improved therapeutic index 伊利诺伊大学评议会 2019-08-23 CN disclosed
CN-105848721-A Amphotericin B derivatives with improved therapeutic index 伊利诺伊大学评议会 2016-08-10 CN disclosed
US-8569528-B2 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides NOVARTIS AG (CH) 2013-10-29 US disclosed
US-20120330026-A1 PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES NOVARTIS AG (CH) 2012-12-27 US disclosed
US-20120238761-A1 PROCESS FOR THE MANUFACTURE OF ORGANIC COMPOUNDS NOVARTIS AG (CH) 2012-09-20 US disclosed
EP-2493848-A1 PROCESS FOR THE MANUFACTURE OF ORGANIC COMPOUNDS Novartis AG (CH) 2012-09-05 EP disclosed
US-20110184187-A1 PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES SEDELMEIER GOTTFRIED 2011-07-28 US disclosed
WO-2007020654-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF LOSARTAN SUVEN LIFE SCIENCES (IN) 2007-02-22 WO disclosed
US-20070043098-A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides NOVARTIS PHARMACEUTICALS CORPORATION 2007-02-22 US disclosed
WO-2007009716-A1 PREPARATION OF TERAZOLE DERIVATIVES NOVARTIS AG (CH) 2007-01-25 WO disclosed
EP-1646636-A1 PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES Novartis AG (CH) 2006-04-19 EP disclosed
US-6933002-B2 Method for manufacturing organic EL device with protective layer DENSO CORPORATION (JP) 2005-08-23 US disclosed
WO-2005014602-A1 PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES NOVARTIS AG (CH) 2005-02-17 WO disclosed
US-6616972-B1 Using as a precursor one or more of, and preferably a combination of, (RRN)xM(=NR)y and (RRN)xM(-R-N=C(R)(R))y where each R is H, alkyl or aryl and M is tantalum,niobium, tungsten or molydenum AIR PRODUCTS AND CHEMICALS, INC. 2003-09-09 US disclosed
US-20030129298-A1 Method for manufacturing organic EL device with protective layer TERA RYONOSUKE (JP) 2003-07-10 US disclosed
US-20010031379-A1 Organic EL device with protective layer DENSO CORPORATION (JP) 2001-10-18 US disclosed